Raju Kapoor

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Electrically active axons degenerate when exposed to nitric oxide

Kenneth J. Smith, Raju Kapoor, Susan Hall et al. · Annals of Neurology · 2001 · 318 citations

Life Sciences, Neurobiology, Neuroscience +16

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

Raju Kapoor, J Furby, Thomas Hayton et al. · The Lancet Neurology · 2010 · 265 citations

Medicine, Neurology, Pharmacotherapy +14

Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration

Raju Kapoor, Meirion Davies, Paul Blaker et al. · Annals of Neurology · 2002 · 251 citations

Life Sciences, Neurology, Neuroscience +17

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial

Rhian Raftopoulos, Simon J. Hickman, Ahmed Toosy et al. · The Lancet Neurology · 2016 · 195 citations · Full text

Medicine, Neurology, Neuroscience +11